The Tokyo Stock Exchange approved the listing of the common shares of wholly owned subsidiary クラサスケミカル株式会社 on the TSE Standard Market. This satisfies one of the conditions for implementing the partial spin-off scheduled for 1 October 2026.
The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.
Petrochemicals business
The impact of implementing this spin-off on the company's consolidated results is still under review and has not been determined at this time.
| Item | Details |
|---|---|
| Transaction name | This spin-off |
| Name of the Subject Company | クラサスケミカル株式会社 |
| Business Description of the Subject Company | Petrochemicals business |
| Type of Consideration | Distribution of クラサスケミカル株式会社 shares as a dividend in kind |
| Voting rights ownership percentage | After Less than 20% (before not disclosed) |
| Impact on Business Performance | The impact of implementing this spin-off on the company's consolidated results is still under review and has not been determined at this time. |
| Date of board resolution | 25 August 2026 |
| Execution Date / Effective Date | 1 October 2026 (予定) |
| Conditions Precedent to Execution | The Tokyo Stock Exchange approves the listing of the shares of クラサスケミカル株式会社 and that approval is not revoked |
| Management structure after acquisition | Following implementation of this spin-off, クラサスケミカル株式会社 is scheduled to cease being a consolidated subsidiary of the company and no longer be subject to equity-method accounting. The shares of クラサスケミカル株式会社 are scheduled to be listed on the TSE Standard Market. |
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The company obtained the Tokyo Stock Exchange's approval to list the shares of クラサスケミカル株式会社, which is a condition for the partial spin-off to take effect. Following the spin-off, クラサスケミカル株式会社 is expected to cease being a consolidated subsidiary and no longer be subject to equity-method accounting, although the impact on consolidated results is still under review.